Shattuck Labs, Inc., headquartered in the United States, is a pioneering biotechnology company focused on advancing the field of immunotherapy. Founded in 2016, Shattuck Labs has quickly established itself as a leader in the development of innovative therapies that harness the power of the immune system to combat cancer and other diseases. The company is renowned for its proprietary platforms, including the unique "Dual-Affinity Re-Targeting" (DART) technology, which enables the creation of bispecific therapeutics that can engage multiple targets simultaneously. This innovative approach sets Shattuck Labs apart in the competitive landscape of biopharmaceuticals. With a strong emphasis on research and development, Shattuck Labs has achieved significant milestones, including strategic partnerships and advancing multiple candidates into clinical trials, solidifying its position as a key player in the immuno-oncology sector.
How does Shattuck Labs, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Shattuck Labs, Inc.'s score of 23 is lower than 71% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Shattuck Labs, Inc., headquartered in the US, currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges associated with the company. This lack of emissions data and formal commitments suggests that Shattuck Labs may still be in the early stages of developing a comprehensive climate strategy. As the industry increasingly prioritises sustainability, it will be essential for Shattuck Labs to establish clear climate commitments and reduction initiatives to align with global standards and expectations.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Shattuck Labs, Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
